Simanainen U, Gao YR, Walters KA, Watson G, Desai R, Jimenez M, Handelsman DJ: Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors. Hormones Cancer. 2012, 3: 113-124.
Article
CAS
PubMed
Google Scholar
Hickey TE, Robinson JL, Carroll JS, Tilley WD: Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?. Mol Endocrinol. 2012, 26: 1252-1267.
Article
CAS
PubMed
PubMed Central
Google Scholar
McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H: Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol. 2013, 133: 66-76.
Article
CAS
PubMed
Google Scholar
Nicolas Diaz-Chico B, German Rodriguez F, Gonzalez A, Ramirez R, Bilbao C, Cabrera de Leon A, Aguirre Jaime A, Chirino R, Navarro D, Diaz-Chico JC: Androgens and androgen receptors in breast cancer. J Steroid Biochem Mol Biol. 2007, 105: 1-15.
Article
CAS
PubMed
Google Scholar
Weihua Z, Lathe R, Warner M, Gustafsson JA: An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci U S A. 2002, 99: 13589-13594.
Article
PubMed
PubMed Central
CAS
Google Scholar
Iwamura M, Abrahamsson PA, Benning CM, Cockett AT, di Sant'Agnese PA: Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J Histochem Cytochem. 1994, 42: 783-788.
Article
CAS
PubMed
Google Scholar
Gasparini P, Fassan M, Cascione L, Guler G, Balci S, Irkkan C, Paisie C, Lovat F, Morrison C, Zhang J, Scarpa A, Croce CM, Shapiro CL, Huebner K: Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options. PLoS ONE. 2014, 9: e88525-
Article
PubMed
PubMed Central
CAS
Google Scholar
Gammon MD, Thompson WD: Polycystic ovaries and the risk of breast cancer. Am J Epidemiol. 1991, 134: 818-824.
Article
CAS
PubMed
Google Scholar
Tomalik-Scharte D, Maiter D, Kirchheiner J, Ivison HE, Fuhr U, Arlt W: Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. Eur J Endocrinol. 2010, 163: 919-924.
Article
CAS
PubMed
PubMed Central
Google Scholar
Medina D: Of mice and women: a short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method. Cold Spring Harbor Perspect Biol. 2010, 2: a004523-
Article
CAS
Google Scholar
Berenblum I: Carcinogenesis and tumor pathogenesis. Advances in Cancer Research. Volume 2. Edited by: Greenstein JP, Haddow A. 1954, Academic Press, New York, 129-175.
Chapter
Google Scholar
Stowers SJ, Maronpot RR, Reynolds SH, Anderson MW: The role of oncogenes in chemical carcinogenesis. Environ Health Perspect. 1987, 75: 81-86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A: Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev. 2004, 18: 1800-1805.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu M, Leav BA, Leav I, Merk FB, Wolfe HJ, Ho SM: Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. Lab Invest. 1993, 68: 33-44.
CAS
PubMed
Google Scholar
Shay H, Harris C, Gruenstein M: Influence of sex hormones on the incidence and form of tumors produced in male or female rats by gastric instillation of methylcholanthrene. J Natl Cancer Inst. 1952, 13: 307-331.
CAS
PubMed
Google Scholar
Shimkin MB, Gropper L, Thatcher D, Gruenstein M: Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823). Cancer Res. 1967, 27: 1284-1288.
CAS
PubMed
Google Scholar
Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 1985, 45: 3415-3443.
CAS
PubMed
Google Scholar
Barhoover MA, Hall JM, Greenlee WF, Thomas RS: Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Mol Pharmacol. 2010, 77: 195-201.
Article
CAS
PubMed
Google Scholar
Monostory K, Pascussi JM, Kobori L, Dvorak Z: Hormonal regulation of CYP1A expression. Drug Metab Rev. 2009, 41: 547-572.
Article
CAS
PubMed
Google Scholar
Wu Y, Baumgarten SC, Zhou P, Stocco C: Testosterone-dependent interaction between androgen receptor and aryl hydrocarbon receptor induces liver receptor homolog 1 expression in rat granulosa cells. Mol Cell Biol. 2013, 33: 2817-2828.
Article
CAS
PubMed
PubMed Central
Google Scholar
Borman SM, Christian PJ, Sipes IG, Hoyer PB: Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol Appl Pharmacol. 2000, 167: 191-198.
Article
CAS
PubMed
Google Scholar
Noble RL, Cutts JH: Mammary tumors of the rat: a review. Cancer Res. 1959, 19: 1125-1139.
CAS
PubMed
Google Scholar
Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH: 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. Faseb J. 2006, 20: 1622-1634.
Article
CAS
PubMed
Google Scholar
Roy D, Cai Q, Felty Q, Narayan S: Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev. 2007, 10: 235-257.
Article
CAS
PubMed
Google Scholar
Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL, Henshall SM, Birrell SN, Coetzee GA, Sutherland RL, Butler LM, Tilley WD: Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res. 2009, 69: 6131-6140.
Article
CAS
PubMed
Google Scholar
Kojima M, Sekimoto M, Degawa M: Androgen-mediated down-regulation of CYP1A subfamily genes in the pig liver. J Endocrinol. 2010, 207: 203-211.
Article
CAS
PubMed
Google Scholar
Aldaz CM, Liao QY, LaBate M, Johnston DA: Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis. 1996, 17: 2069-2072.
Article
CAS
PubMed
Google Scholar
Kemppainen JA, Langley E, Wong CI, Bobseine K, Kelce WR, Wilson EM: Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol Endocrinol. 1999, 13: 440-454.
Article
CAS
PubMed
Google Scholar
Burek JD: Pathology of Aging Rats. 1978, CRC Press, Boca Raton, Florida
Google Scholar
Nathanson IT, Andervont HB: Effect of testosterone propionate on development and growth of mammary carcinoma in female mice. Exp Biol Med. 1939, 40: 421-422.
Article
CAS
Google Scholar
Darbre P, Page M, King RJ: Androgen regulation by the long terminal repeat of mouse mammary tumor virus. Mol Cell Biol. 1986, 6: 2847-2854.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hodgson MC, Vanostran G, Alghamdi S, Poppiti RJ, Agoulnik AI, Agoulnik IU: Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. PLoS ONE. 2013, 8: e60455-
Article
CAS
PubMed
PubMed Central
Google Scholar
Martin AM, Weber BL: Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst. 2000, 92: 1126-1135.
Article
CAS
PubMed
Google Scholar
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G: Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009, 360: 573-587.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cardiff RD: Validity of mouse mammary tumour models for human breast cancer: comparative pathology. Microsc Res Technique. 2001, 52: 224-230.
Article
CAS
Google Scholar
Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN: Squamous cell carcinoma of the breast. J Clin Oncol. 2005, 23: 7827-7835.
Article
PubMed
Google Scholar
Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990, 62: 244-278.
CAS
PubMed
Google Scholar
Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci U S A. 1995, 92: 3650-3657.
Article
CAS
PubMed
PubMed Central
Google Scholar
Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007, 8: R76-
Article
PubMed
PubMed Central
CAS
Google Scholar
Briziarelli G: Effects of dosage and time of administration of testosterone propionate on 7,12-dimethylbenzanthracene mammary carcinogenesis in the rat. Z Krebsforsch. 1965, 66: 517-522.
Article
CAS
Google Scholar
Briziarelli G: Effects of hormonal pre-treatment against the induction of mammary tumors by 7,12-dimethylbenz[a]anthracene in rats. Z Krebsforsch. 1966, 68: 217-223.
Article
CAS
PubMed
Google Scholar
Li S, Yan X, Belanger A, Labrie F: Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat. Breast Cancer Res Treat. 1993, 29: 203-217.
Article
Google Scholar
Luo S, Labrie C, Belanger A, Labrie F: Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat. Endocrinology. 1997, 138: 3387-3394.
Article
CAS
PubMed
Google Scholar
Kohama T, Terada S, Suzuki N, Inoue M: Effects of dehydroepiandrosterone and other sex steroid hormones on mammary carcinogenesis by direct injection of 7,12-dimethylbenz(a) anthracene (DMBA) in hyperprolactinemic female rats. Breast Cancer Res Treat. 1997, 43: 105-115.
Article
CAS
PubMed
Google Scholar
Shay H, Gruenstein M, Kessler W: Experimental mammary adenocarcinoma of rats: some considerations of methyl-cholanthrene dosage and hormonal treatment. J Natl Cancer Inst. 1961, 27: 503-513.
Google Scholar
Lubet RA, Gordon GB, Prough RA, Lei XD, You M, Wang Y, Grubbs CJ, Steele VE, Kelloff GJ, Thomas CF, Moon RD: Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. Cancer Res. 1998, 58: 921-926.
CAS
PubMed
Google Scholar
Bartsch W, Klein H, Schiemann U, Bauer HW, Voigt KD: Enzymes of androgen formation and degradation in the human prostate. Ann N Y Acad Sci. 1990, 595: 53-66.
Article
CAS
PubMed
Google Scholar
Huggins C, Mainzer K, Briziarelli G: Molecular structure of steroids and phenanthrene derivatives related to growth of transplanted mammary tumors. Recent Prog Horm Res. 1958, 14: 77-87. discussion 88?93
CAS
PubMed
Google Scholar
Peters AA, Ingman WV, Tilley WD, Butler LM: Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland. Endocrinology. 2011, 152: 3728-3737.
Article
CAS
PubMed
Google Scholar
Cheung SY, Yuen MT, Choi HL, Cheng HK, Huang Y, Chen S, Chan FL: An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats. Int J Oncol. 2003, 22: 1383-1395.
CAS
PubMed
Google Scholar
Dauvois S, Li SM, Martel C, Labrie F: Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res Treat. 1989, 14: 299-306.
Article
CAS
PubMed
Google Scholar
Kovacs K: Effect of androgenization on the development of mammary tumors in rats induced by the oral adminstration of 9,10-dimethyl-1,2-benzanthracene. Br J Cancer. 1965, 19: 531-537.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shellabarger CJ, Soo VA: Effects of neonatally administered sex steroids on 7,12-dimethylbenz(a)anthracene-induced mammary neoplasia in rats. Cancer Res. 1973, 33: 1567-1569.
CAS
PubMed
Google Scholar
Christakos S, Sinha D, Dao TL: Neonatal modification of endocrine functions and mammary carcinogenesis in the rat. Br J Cancer. 1976, 34: 58-63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoshida H, Kadota A, Fukunishi R, Matsumoto K: Induction of mammary dysplasia and mammary carcinoma in neonatally androgenized female rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst. 1980, 64: 1105-1112.
CAS
PubMed
Google Scholar
Purnell DM: The effects of neonatal androgenization on mammary gland mitotic rate and susceptibility of carcinogen-induced mammary dysplastigenesis and tumorigenesis in LEW/Mai rats. Am J Pathol. 1980, 99: 463-474.
CAS
PubMed
PubMed Central
Google Scholar
Verhoeven G, Vandoren G, Heyns W, Kuhn ER, Janssens JP, Teuwen D, Goddeeris P, Lesaffre E, De Moor P: Incidence, growth and oestradiol-receptor levels of 7, 12-dimethylbenz (alpha) anthracene-induced mammary tumours in rats: effects of neonatal sex steroids and oestradiol implants. J Endocrinol. 1982, 95: 357-368.
Article
CAS
PubMed
Google Scholar
Yoshida H, Fukunishi R, Kato Y, Matsumoto K: Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats. J Natl Cancer Inst. 1980, 65: 823-828.
Article
CAS
PubMed
Google Scholar
Dao TL: Mammary tumorigenesis in female rats receiving androgen neonatally. Proc Am Assoc Cancer Res. 1966, 7: 16-
Google Scholar
Young S, Baker RA, Helfenstein JE: The effects of androgens on induced mammary tumours in rats. Br J Cancer. 1965, 19: 155-159.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heise E, Gorlich M: Growth and therapy of mammary tumours induced by 7,12-dimethylbenzanthracene in rats. Br J Cancer. 1966, 20: 539-545.
Article
CAS
PubMed
PubMed Central
Google Scholar
Teller MN, Stock CC, Bowie M: Effects of 17-alpha-thioestradiol, 2 estradiol analogs, and 2 androgens on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Cancer Res. 1966, 26: 2329-2333.
CAS
PubMed
Google Scholar
Teller MN, Kaufman RJ, Stock CC, Bowie M: Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system. Cancer Res. 1968, 28: 368-371.
CAS
PubMed
Google Scholar
Teller MN, Kaufman RJ, Bowie M, Stock CC: Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Cancer Res. 1969, 29: 349-352.
CAS
PubMed
Google Scholar
Teller MN, Stock CC, Hellman L, Mountain IM, Bowie M, Rosenberg BJ, Boyar RM, Budinger JM: Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res. 1977, 37: 3932-3938.
CAS
PubMed
Google Scholar
Teller MN, Stock CC, Bowie M, Chou TC, Budinger JM: Therapy of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2 alpha-methyldihydrotestosterone propionate. Cancer Res. 1982, 42: 4408-4412.
CAS
PubMed
Google Scholar
Mobbs BG: The effect of testosterone treatment on the uptake of [3H] oestradiol-17 beta by dimethylbenzanthracene-induced rat mammary tumours. J Endocrinol. 1970, 48: 293-294.
Article
CAS
PubMed
Google Scholar
Griswold DP, Green CH: Observations on the hormone sensitivity of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors in the Sprague?Dawley rat. Cancer Res. 1970, 30: 819-826.
CAS
PubMed
Google Scholar
Briziarelli G, Castelli P, Vitali R, Gardi R: 9?-Fluoro-11?-hydroxybenzo [d, e] testosterone 17-acetate. A modified steroid highly active on DMBA-induced mammary tumors in rats. Experientia. 1972, 29: 618-619.
Article
Google Scholar
Takahashi T, Nakamura T, Majima S: Effect of ovariectomy and androgen on the growth of mammary tumors induced by 7,12-dimethylbenz (alpha)-anthracene in rats. Jpn J Surg. 1973, 3: 229-236.
Article
CAS
PubMed
Google Scholar
Quadri SK, Kledzik GS, Meites J: Counteraction by prolactin of androgen-induced inhibition of mammary tumor growth in rats. J Natl Cancer Inst. 1974, 52: 875-878.
Article
CAS
PubMed
Google Scholar
Horn H, Erlichman I, Levij IS: Anti-tumour efficacy of calusterone against DMBA-induced rat mammary adenocarcinoma in vivo and in organ culture. Br J Cancer. 1976, 33: 336-341.
Article
CAS
PubMed
PubMed Central
Google Scholar
Costlow ME, Buschow RA, McGuire WL: Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma. Cancer Res. 1976, 36: 3324-3329.
CAS
PubMed
Google Scholar
Zava DT, McGuire WL: Estrogen receptors in androgen-induced breast tumor regression. Cancer Res. 1977, 37: 1608-1610.
CAS
PubMed
Google Scholar
Boccuzzi G, Aragno M, Brignardello E, Tamagno E, Conti G, Di Monaco M, Racca S, Danni O, Di Carlo F: Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Anticancer Res. 1992, 12: 1479-1483.
CAS
PubMed
Google Scholar
Boccuzzi G, Tamagno E, Brignardello E, Di Monaco M, Aragno M, Danni O: Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide. J Cancer Res Clin Oncol. 1995, 121: 150-154.
Article
CAS
PubMed
Google Scholar
Gatto V, Aragno M, Gallo M, Tamagno E, Martini A, Di Monaco M, Brignardello E, Boccuzzi G: Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. Oncol Rep. 1998, 5: 241-243.
CAS
PubMed
Google Scholar
Spinola PG, Marchetti B, Merand Y, Belanger A, Labrie F: Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Res Treat. 1988, 12: 287-296.
Article
CAS
PubMed
Google Scholar
Ercoli A, Briziarelli G: Effect of enol-ether derivatives of dihydrotestosterone on 3-methylcholanthrene-induced rat mammary carcinoma. J Natl Cancer Inst. 1961, 27: 1173-1187.
CAS
PubMed
Google Scholar
Nguyen TV, Yao M, Pike CJ: Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection. Endocrinology. 2007, 148: 2936-2943.
Article
CAS
PubMed
Google Scholar
van Weerden WM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schroder FH: Adrenal glands of mouse and rat do not synthesize androgens. Life Sci. 1992, 50: 857-861.
Article
CAS
PubMed
Google Scholar
Di Monaco M, Brignardello E, Leonardi L, Gatto V, Gallo M, Pizzini A, Boccuzzi G: The antiandrogen flutamide inhibits growth of mcf-7 human breast-cancer cell-line. Int J Oncol. 1993, 2: 653-656.
CAS
Google Scholar
Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M, Neufing PJ, Coetzee GA, Tilley WD: Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum Mol Genet. 2004, 13: 1677-1692.
Article
CAS
PubMed
Google Scholar
Simanainen U, Brogley M, Gao YR, Jimenez M, Harwood DT, Handelsman DJ, Robins DM: Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Mol Cell Endocrinol. 2011, 342: 81-86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Albertelli MA, Scheller A, Brogley M, Robins DM: Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol. 2006, 20: 1248-1260.
Article
CAS
PubMed
Google Scholar
Yu H, Bharaj B, Vassilikos EJ, Giai M, Diamandis EP: Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat. 2000, 59: 153-161.
Article
CAS
PubMed
Google Scholar
Zaccheo T, Di Salle E: Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone. Cancer Chemother Pharmacol. 1989, 25: 95-98.
Article
CAS
PubMed
Google Scholar
Abul-Hajj YJ: The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors. J Steroid Biochem. 1989, 34: 439-442.
Article
CAS
PubMed
Google Scholar
Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE: Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol. 2002, 20: 751-757.
Article
CAS
PubMed
Google Scholar
Fisher CR, Graves KH, Parlow AF, Simpson ER: Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A. 1998, 95: 6965-6970.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER: Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000, 97: 12735-12740.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tekmal RR, Ramachandra N, Gubba S, Durgam VR, Mantione J, Toda K, Shizuta Y, Dillehay DL: Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res. 1996, 56: 3180-3185.
CAS
PubMed
Google Scholar
Li X, Warri A, Makela S, Ahonen T, Streng T, Santti R, Poutanen M: Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology. 2002, 143: 4074-4083.
Article
CAS
PubMed
Google Scholar
Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Lang I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B: Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1?98 randomised clinical trial at 8.1?years median follow-up. Lancet Oncol. 2011, 12: 1101-1108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cramer W: The hormonal aetiology of breast cancer. Am J Cancer. 1940, 38: 463-472.
CAS
Google Scholar
Cutts JH: Estrone-induced mammary tumors in the rat: II. Effect of alterations in the hormonal environment on tumor induction, behavior, and growth. Cancer Res. 1964, 24: 1124-1130.
CAS
Google Scholar
Cutts JH: Unusual response to androgen of estrogen-dependent mammary tumors. J Natl Cancer Inst. 1969, 42: 485-488.
CAS
PubMed
Google Scholar
Noble RL: A new characteristic transplantable type of breast carcinoma in Nb rats following combined estrogen-androgen treatment. Proc Am Assoc Cancer Res. 1976, 17: 221-
Google Scholar
Liao DZ, Pantazis CG, Hou X, Li SA: Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. Carcinogenesis. 1998, 19: 2173-2180.
Article
CAS
PubMed
Google Scholar
Xie B, Tsao SW, Wong YC: Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens. Carcinogenesis. 1999, 20: 1597-1606.
Article
CAS
PubMed
Google Scholar
Xie B, Tsao SW, Wong YC: Induction of high incidence of mammary tumour in female Noble rats with a combination of 17beta-oestradiol and testosterone. Carcinogenesis. 1999, 20: 1069-1078.
Article
CAS
PubMed
Google Scholar
Heiman J: The effect of androgens and estrogens on spontaneous benign mammary tumors in the rat. Am J Cancer. 1940, 40: 343-354.
CAS
PubMed
Google Scholar
Huggins C, Mainzer K: Hormonal influences on mammary tumors of the rat. II. Retardation of growth of a transplanted fibroadenoma in intact female rats by steroids in the androstane series. J Exp Med. 1957, 105: 485-500.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones EE: The effect of testosterone propionate on mammary tumors in mice of the C3H strain. Cancer Res. 1941, 1: 787-789.
CAS
Google Scholar
Lacassagne A, Raynaud A: Sur le mechanisme d'une action preventive de la testosterone sur le carcinome mammaire de la souris. Compt Rend Soc Biol. 1939, 131: 586-
CAS
Google Scholar
Loeser AA: Mammary carcinoma response to implantation of male hormone and progesterone. The Lancet. 1941, 238: 698-700.
Article
Google Scholar
Schwartz AG: Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 1979, 39: 1129-1132.
CAS
PubMed
Google Scholar
Heiman J: Effect of testosterone propionate on the adrenals and on the incidence of mammary cancer in the RIII strain of mice. Cancer Res. 1944, 4: 31-34.
CAS
Google Scholar
Yanai R, Nagasawa H, Mori T, Nakajima Y: Long-term effects of perinatal exposure to 5 alpha-dihydrotestosterone on normal and neoplastic mammary development in mice. Endocrinol Jpn. 1981, 28: 231-234.
Article
CAS
PubMed
Google Scholar
Mori T, Bern HA, Mills KT, Young PN: Long-term effects of neonatal steroid exposure on mammary gland development and tumorigenesis in mice. J Natl Cancer Inst. 1976, 57: 1057-1062.
Article
CAS
PubMed
Google Scholar
Watson PA, Kim K, Chen KS, Gould MN: Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene. Cancer Cell. 2002, 2: 67-79.
Article
CAS
PubMed
Google Scholar
Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell K, Rugo H, Nabell L, Forero A, Stearns V, Doane AS, Danso M, Moynahan ME, Momen LF, Gonzalez JM, Akhtar A, Giri DD, Patil S, Feigin KN, Hudis CA, Traina TA: Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer. Clin Cancer Res. 2013, 19: 5505-5512.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R: The effects of tibolone in older postmenopausal women. N Engl J Med. 2008, 359: 697-708.
Article
CAS
PubMed
PubMed Central
Google Scholar
ClinicalTrials.gov [], [https://clinicaltrials.gov/]
Small EJ, Carroll PR: Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome. Urology. 1994, 43: 408-410.
Article
CAS
PubMed
Google Scholar